Share of people with HIV who receive antiretroviral therapy in France
France: Share of people with HIV who receive antiretroviral therapy was 91.0% in 2022. ▲ Rising
Share of people with HIV who receive antiretroviral therapy in France, 2000–2022
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
France recorded 91.0% for share of people with hiv who receive antiretroviral therapy in 2022. That is the highest value across all 23 years on record.
That represents a change of up 1.1% on the previous year and up 5.8% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in France peaked at 91.0% in 2022 and was at its lowest, 76.0%, in 2000.
That places France 17th out of 143 countries with data for 2022, putting it in the top quarter.
The long-run direction has been consistently rising across the 23 years of available data.
Share of people with HIV who receive antiretroviral therapy in France, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 76.0% | — |
| 2001 | 77.0% | +1.3% |
| 2002 | 78.0% | +1.3% |
| 2003 | 79.0% | +1.3% |
| 2004 | 79.0% | +0.0% |
| 2005 | 80.0% | +1.3% |
| 2006 | 81.0% | +1.2% |
| 2007 | 82.0% | +1.2% |
| 2008 | 83.0% | +1.2% |
| 2009 | 84.0% | +1.2% |
| 2010 | 85.0% | +1.2% |
| 2011 | 86.0% | +1.2% |
| 2012 | 86.0% | +0.0% |
| 2013 | 87.0% | +1.2% |
| 2014 | 88.0% | +1.1% |
| 2015 | 90.0% | +2.3% |
| 2016 | 90.0% | +0.0% |
| 2017 | 90.0% | +0.0% |
| 2018 | 89.0% | -1.1% |
| 2019 | 89.0% | +0.0% |
| 2020 | 89.0% | +0.0% |
| 2021 | 90.0% | +1.1% |
| 2022 | 91.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 79.9% | 76.0% | 84.0% | 10 |
| 2010s | 88.0% | 85.0% | 90.0% | 10 |
| 2020s | 90.0% | 89.0% | 91.0% | 3 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Population ages 65-69, male, annual growth rate 0.918 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0277 units per person (2025)
- Population ages 70-74, female, annual growth rate -0.1141 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per capita 0.0296 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in France?
- Share of people with hiv who receive antiretroviral therapy in France was 91.0% in 2022, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in France?
- The highest recorded value was 91.0% in 2022.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in France?
- The lowest recorded value was 76.0% in 2000.
- How does France rank for share of people with hiv who receive antiretroviral therapy?
- France ranks 17th out of 143 countries with data for 2022.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in France?
- Over the last ten years it is up 5.8%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.